Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Here At Last: Canada’s Long-Contested Guidelines For Curbing Excessive Drug Prices
Jul 04 2025
•
By
Neena Brizmohun
New guidelines explain how Canada will ensure that drug prices are not excessive
(Shutterstock/Stefan Malloch)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Pricing Debate
More from Market Access